ethambutol,

Ethambutol-D4 dihydrochloride is a deuterated compound of Ethambutol.2hydrochloride.

Ethambutol.2Hcl-D4 (Standard) is a reference standard of Ethambutol.2Hcl-D4 intended for quantitative analysis, quality control, and related biochemical research applications. Ethambutol.2HCl-d4 is a deuterated compound of Ethambutol.2HCl.

Ethambutol, (R, R)- can be used to treat tuberculosis. It is usually used in combination with other tuberculosis medications. It may also be used to treat Mycobacterium avium complex, and Mycobacterium kansasii.

Ethambutol dihydrochloride is an anti-mycobacterial compound that inhibits arabinosyl transferase activity to prevent cell wall formation and can be used to induce hyperuricemia models.

Ethambutol is an oral anti-tuberculosis drug that inhibits arabinosyl transferase activity, thereby interfering with the synthesis of arabinogalactan and preventing cell wall formation to exert its antibacterial effect; it can also be used for animal models of hyperuricemia and optic neuropathy.

Ethambutol-D10 is the deuterated form of Ethambutol. Ethambutol (T7062) acts as an antimycobacterial agent by inhibiting the activity of arabinosyl transferase, thereby preventing the formation of the bacterial cell wall.

Ethambutol-D8 is a deuterated compound of Ethambutol. Ethambutol (T7062) has a CAS number of 74-55-5. Ethambutol (T7062) is a bacteriostatic antimycobacterial agent obstructed the formation of cell wall by inhibiting arabinosyl transferases.

Ethambutol dihydrochloride (Standard) is a reference standard for research and analysis in studies involving Ethambutol dihydrochloride. Ethambutol dihydrochloride is an anti-mycobacterial compound that inhibits arabinosyl transferase activity to prevent cell wall formation and can be used to induce hyperuricemia models.

Ethambutol-KLH is a hapten-carrier protein conjugate formed by linking ethambutol to KLH (kalnex lymphocyte histidine-containing leukocyte antigen). It enhances the immune response induced by Ethambutol through hapten-protein adjuvant binding and is commonly used in vaccine or antibody preparation studies.

Ethambutol-BSA is a hapten-carrier protein conjugate formed by linking ethambutol to BSA (bovine serum albumin). It enhances the immune response induced by Ethambutol by combining a hapten with a protein adjuvant and is commonly used in vaccine or antibody studies.

Dinitrosoethambutol is a biochemical.

SQ109 (NSC 722041) is an ethambutol (EMB) derivative and a specific inhibitor of MmpL3, exhibiting potent anti-Mycobacterium tuberculosis activity. SQ109 effectively inhibits the adult stage of the parasite Trypanosoma and kills cells, with an IC50 of 50 ± 8 nM. SQ109 can be used in tuberculosis and antiparasitic research.

UH-NIP-16 exhibits antibacterial activity against Mycobacterium tuberculosis, effectively inhibiting the pathogenic mycobacterium strains H37Rv and CDC1551 with MIC50 values of 1.86 and 3.05 μM, respectively. Additionally, UH-NIP-16 synergistically enhances the antitubercular effects when used with antituberculosis agents such as Streptomycin, Isoniazid, Ethambutol, and Bedaquiline.

OPC-167832 is a highly potent and orally bioavailable dprE1 inhibitor with an IC₅₀ of 0.258 μM. It exhibits anti-mycobacterial activity against Mycobacterium tuberculosis and can be used in tuberculosis-related research.